Literature DB >> 3303066

Perspectives in platelet-activating factor research.

P Braquet, L Touqui, T Y Shen, B B Vargaftig.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3303066

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  267 in total

1.  Effects of genotypically different strains of Helicobacter pylori on human microvascular endothelial cells in vitro.

Authors:  N Kalia; C Jones; D K Bardhan; M W Reed; J C Atherton; N J Brown
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 2.  Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma.

Authors:  J P Doucet; N G Bazan
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

3.  Inflammatory mediators are involved in the Candida albicans killing activity of human epidermal cells.

Authors:  M Csato; A S Kenderessy; R Judák; A Dobozy
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

4.  Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig.

Authors:  N A Flores; D J Sheridan
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

Review 5.  New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists.

Authors:  P Braquet; A Esanu
Journal:  Agents Actions       Date:  1991-01

6.  Allergen-induced bronchospasm in passively sensitized guinea pigs: influence of new substances in comparison to reference compounds.

Authors:  S Madi; J Giessler; R Hirschelmann; G Friedrich; P Braquet
Journal:  Agents Actions       Date:  1991-01

Review 7.  The pharmacology of airway hyperresponsiveness and inflammation.

Authors:  R Pauwels
Journal:  Lung       Date:  1990       Impact factor: 2.584

8.  Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages.

Authors:  A G Stewart; W A Phillips
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

9.  TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.

Authors:  P Canale; F Squadrito; D Altavilla; M Ioculano; B Zingarelli; G M Campo; G Urna; A Sardella; G Squadrito; A P Caputi
Journal:  Agents Actions       Date:  1994-10

10.  Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.

Authors:  C Szabó; J A Mitchell; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.